Enterprise Value
100.3M
Cash
9.144M
Avg Qtr Burn
-1.624M
Short % of Float
3.14%
Insider Ownership
54.21%
Institutional Own.
6.46%
Qtr Updated
09/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GLSI-100 Details Breast cancer | Phase 3 Update |